Cargando…

Anti-Analgesic Effect of the Mu/Delta Opioid Receptor Heteromer Revealed by Ligand-Biased Antagonism

Delta (DOR) and mu opioid receptors (MOR) can complex as heteromers, conferring functional properties in agonist binding, signaling and trafficking that can differ markedly from their homomeric counterparts. Because of these differences, DOR/MOR heteromers may be a novel therapeutic target in the tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milan-Lobo, Laura, Enquist, Johan, van Rijn, Richard M., Whistler, Jennifer L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598907/ https://www.ncbi.nlm.nih.gov/pubmed/23554887 http://dx.doi.org/10.1371/journal.pone.0058362

Ejemplares similares

Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers
por: Fujita, Wakako, et al.
Publicado: (2014)

Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors
por: Ong, Edmund W., et al.
Publicado: (2014)

Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding Effects
por: Requana Aradas, Ariadna, et al.
Publicado: (2023)

Putative Kappa Opioid Heteromers As Targets for Developing Analgesics Free of Adverse Effects
por: Le Naour, Morgan, et al.
Publicado: (2014)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
por: Zamora, Joshua C., et al.
Publicado: (2021)

In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
por: Zhang, Xiao, et al.
Publicado: (2020)

Investigation of Receptor Heteromers Using NanoBRET Ligand Binding
por: Johnstone, Elizabeth K. M., et al.
Publicado: (2021)

The Meta-Position of Phe(4) in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors
por: Cassell, Robert J., et al.
Publicado: (2019)

Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes
por: Derouiche, Lyes, et al.
Publicado: (2020)

Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
por: Vidal-Torres, Alba, et al.
Publicado: (2023)

Chronic Ethanol Consumption in Rats Produces Opioid Antinociceptive Tolerance through Inhibition of Mu Opioid Receptor Endocytosis
por: He, Li, et al.
Publicado: (2011)

Biased Opioid Ligands
por: Faouzi, Abdelfattah, et al.
Publicado: (2020)

Biased Signaling of the Mu Opioid Receptor Revealed in Native Neurons
por: Ehrlich, Aliza T., et al.
Publicado: (2019)

Dezocine is a Biased Ligand without Significant Beta-Arrestin Activation of the mu Opioid Receptor
por: Grothusen, John, et al.
Publicado: (2022)

An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function
por: Rozenfeld, Raphael, et al.
Publicado: (2007)

Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships
por: Journigan, V. Blair, et al.
Publicado: (2017)

A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism
por: Gris, Pavel, et al.
Publicado: (2010)

Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade
por: Trøstheim, Martin, et al.
Publicado: (2022)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Activity of opioid ligands in cells expressing cloned mu opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2003)

Ligand‐specific recycling profiles determine distinct potential for chronic analgesic tolerance of delta‐opioid receptor (DOPr) agonists
por: Bagheri Tudashki, Hanieh, et al.
Publicado: (2020)

Morphine-induced mu opioid receptor trafficking enhances reward yet prevents compulsive drug use
por: Berger, Amy Chang, et al.
Publicado: (2011)

The novel use of mu-opioid receptor antagonism for the treatment of refractory pruritus in Kyrle’s disease()()
por: Forouzandeh, Mahtab, et al.
Publicado: (2019)

Biased versus Partial Agonism in the Search for Safer Opioid Analgesics
por: Azevedo Neto, Joaquim, et al.
Publicado: (2020)

Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs
por: Franco, Rafael, et al.
Publicado: (2023)

MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys
por: Aceto, Mario D., et al.
Publicado: (2012)

Biased Opioid Ligands: Revolution or Evolution?
por: Noble, Florence, et al.
Publicado: (2021)

Role of Mu and Delta Opioid Receptors in the Nucleus Accumbens in Cocaine-Seeking Behavior
por: Simmons, Diana, et al.
Publicado: (2009)

Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits
por: Wang, Dong, et al.
Publicado: (2018)

Kappa but not delta or mu opioid receptors form homodimers at low membrane densities
por: Cechova, Kristina, et al.
Publicado: (2021)

A mu–delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks
por: Erbs, Eric, et al.
Publicado: (2014)

Hydrogen Sulfide Inhibits Inflammatory Pain and Enhances the Analgesic Properties of Delta Opioid Receptors
por: Porta, Aina, et al.
Publicado: (2021)

New Insights on Expression and Function of Mu and Delta Opioid Receptors in Mouse Gastrointestinal Tract
por: Feng, Bin
Publicado: (2020)

Convergent, functionally independent signaling by mu and delta opioid receptors in hippocampal parvalbumin interneurons
por: He, Xinyi Jenny, et al.
Publicado: (2021)

Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors
por: Meqbil, Yazan J., et al.
Publicado: (2022)

Analgesic tolerance of opioid agonists in mutant mu-opioid receptors expressed in sensory neurons following intrathecal plasmid gene delivery
por: Li, Guangwen, et al.
Publicado: (2013)

Receptor and Channel Heteromers as Pain Targets
por: Berg, Kelly A., et al.
Publicado: (2012)

Heteromer Nanostars by Spontaneous Self-Assembly
por: Brocker, Caitlin, et al.
Publicado: (2017)

Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors
por: Zaveri, Nurulain T., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v6as2h64mmdvl559eaj9og3ona